Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
This study has been completed.
Study NCT01571297 Information provided by Rhythm Pharmaceuticals, Inc.
First Received on April 2, 2012. Last Updated on November 6, 2014
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetes Mellitus Complications
Additional conditions recognized in this trial
More general conditions related to this trial
Digestive System Diseases
Endocrine System Diseases
Glucose Metabolism Disorders
Signs and Symptoms
Interventions listed in this trial
Sponsors listed in this trial
Rhythm Pharmaceuticals, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers